Biology subjects

Gockert, M.

Publications and source records attributed to Gockert, M..

4 recordsLinked to original sources

bioRxiv2026

Expanding the chemical diversity of RNA by transcriptional incorporation of amino acid- and glycosyl-modified nucleotides

With the increasing interest in RNA-based therapies, there is a pressing need to incorporate new chemistries into more complex RNA molecules. These modifications can protect RNA from degradation, improve its pharmacokinetics, and enhance its targeting properties. Here we describe the enzymatic synthesis of chemically modified RNA derivatives using a mutant T7 RNA polymerase to incorporate 23 different base modifications alongside stabilizing ribose modifications, such as 2'-fluoro and 2'-deoxy groups. To investigate the impact on transcription efficiency and fidelity, we employed a pool of 38 template sequences and analyzed the transcripts by next-generation sequencing of the cDNA. Results demonstrated that all modifications were successfully incorporated into RNA, with transcription efficiency influenced by three main factors: type of modification, base modified, and the sequence context. Misincorporation levels during transcription and reverse transcription into cDNA were generally low (<1%) but included noticeable exceptions for some nucleobase-modification combinations. As a robust proof-of-concept we demonstrated the selection of Histidine-U modified aptamer, relying on multiple rounds of transcription and amplification, binding Influenza hemagglutinin protein with low nanomolar KD. We anticipate that this work will significantly contribute to the design and production of chemically modified RNAs with novel functionalities, advancing applications in biomedicine and synthetic biology. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=76 SRC="FIGDIR/small/720138v2_ufig1.gif" ALT="Figure 1"> View larger version (16K): org.highwire.dtl.DTLVardef@29b6daorg.highwire.dtl.DTLVardef@a3c425org.highwire.dtl.DTLVardef@1a27a4aorg.highwire.dtl.DTLVardef@ab0e9_HPS_FORMAT_FIGEXP M_FIG C_FIG

molecular biology↗

bioRxiv2025

Native extracellular vesicles display surface bound RNAs that are co-delivered to cells

Extracellular vesicles (EVs) can transport functional RNA between cells and therefore hold great potential for diagnostics and RNA-based therapeutics. Classically, RNA is believed to be encapsulated in the EV lumen. However, it has recently been demonstrated that cells present RNA on their surface. This RNA was found to be glycosylated, and although glycosylated tRNA was also found in EVs, its exact location remained elusive. Here, we demonstrate the presence of RNA on the surface of mesenchymal stem cell (MSC) derived EVs. By combining single-vesicle measurements with direct and selective visualization of RNA, we introduce surface RNA (surfRNA) as a new inherent component of EVs. RNA sequencing supports the surface localization of this RNA and further identifies tRNA fragments as primary constituent of surfRNA. Importantly, surfRNA is co-delivered to target cells together with EVs, suggesting a yet unrecognized uptake route of extracellular RNA. A deeper understanding of the surface-associated RNA may have significant implications for EV biogenesis, targeting, and downstream functional effects. We further envision that these findings are transferable to other nanoparticles and will thereby advance the field of therapeutic RNA delivery.

molecular biology↗

bioRxiv2025

Optimizing C14120-based LNPs for in vitro and in vivo mRNA delivery

Lipid nanoparticles (LNPs) have proven to be an effective delivery system for RNA therapeutics. The chemical composition of LNPs determines their functional delivery efficiency and targeting properties, which vary between in vitro and in vivo contexts. Here, we have systematically characterized and compared twenty-five novel C14120-based LNP formulations for mRNA delivery in vitro and assessed in vivo mRNA expression and biodistribution using deep sequencing of DNA barcodes in a pooled LNP-mRNA library. In vitro experiments showed correlations of lipid composition with particle size and mRNA transfection efficiency in 4 different cell lines of distinct tissue and species origin. In vivo experiments employed a pooled LNP delivery of luciferase mRNA in combination with a multiplexed barcode system, revealed strong mRNA expression after 6 hours and identified LNP compositions with organ-specific targeting properties. Individual validation of three selected LNP candidates based on mRNA expression analysis confirmed high specificity for the lung-targeting candidate, lower specificity for the liver-targeting candidate, and inconclusive results for the spleen-targeting candidate. These findings identify LNP formulations with promising potential for in vitro and in vivo organ-targeted delivery.

bioengineering↗

bioRxiv2023

Dual agonistic and antagonistic roles of ZC3H18 provides for co-activation of distinct nuclear RNA decay pathways

The RNA exosome is a versatile ribonuclease. In the nucleoplasm of mammalian cells, it is assisted by its adaptors the Nuclear EXosome Targeting (NEXT) complex and the PolyA eXosome Targeting (PAXT) connection. Via its association with the ARS2 and ZC3H18 proteins, NEXT/exosome is recruited to capped and short unadenylated transcripts. Conversely, PAXT/exosome was considered to target longer and adenylated substrates via their poly(A) tails. Here, mutational analysis of the core PAXT component ZFC3H1 uncovers a separate branch of the PAXT pathway, which targets short adenylated RNAs and relies on a direct ARS2-ZFC3H1 interaction. We further demonstrate that similar acidic-rich short linear motifs of ZFC3H1 and ZC3H18 compete for a common ARS2 epitope. Consequently, while promoting NEXT function, ZC3H18 antagonizes PAXT activity. We suggest that this unprecedented organization of RNA decay complexes provides co-activation of NEXT and PAXT at loci with abundant production of short exosome substrates.

molecular biology↗